IP-NFTs for Researchers: A New Biomedical Funding Paradigm

In a first step, Molecule provides an interoperable Web3 marketplace leveraging a scalable legal IP to NFT framework. Our novel approach allows for IP to be virtualized and modularised in an open bazaar. To achieve this, we utilize a combination of unique digital asset identifiers (NFTs), novel automatic exchange infrastructure (AMMs) and governanc... See more

I deeply believe that the Trojan horse for crypto adoption is intellectual property (IP) because of its ability to create trust and credibility in a space that lacks the ladder, and memecoins, like NFTs, are a form of IP.

What excites me the most about these kinds of projects is that they combine multiple kinds of cutting-edge business models and technologies — digital scarcity, drop culture, blockchain and cryptocurrency — into a direct-to-fan transaction that actually makes real money for the artists involved.

A GIANT leap for decentralized research was made today 🧬 For the first time, real-world biopharma research and IP was transferred and funded on-chain as an NFT via @Molecule_to @Nevermined_io @vita_dao A DAO now owns IP and funds biotech research at a leading lab... 👇 1/🧵

On the crypto side, we should watch to see whether new initiatives:-Are able to generate and distribute funding for science work;-Produce research that is recognized by the wider science community;-Generate uncapped rewards (financially or otherwise) for participating scientists